logo
Merck & Co., Inc. (MRK) Files for Global Approval of Pimicotinib After Positive Phase III TGCT Results

Merck & Co., Inc. (MRK) Files for Global Approval of Pimicotinib After Positive Phase III TGCT Results

Yahoo29-05-2025
Merck & Co., Inc. (NYSE:MRK) is seeking worldwide regulatory approval for its CSF-1R inhibitor pimicotinib following robust Phase III results in tenosynovial giant cell tumour (TGCT). The MANEUVER trial, conducted with Abbisko Therapeutics, showed a 61.9% overall response rate (ORR) by tumour volume score (TVS) after 25 weeks, far surpassing placebo (3.2%). This efficacy outperformed Daiichi Sankyo's Turalio (56% ORR) and was just behind Ono Pharmaceutical's Romvimza (67% ORR), which received FDA approval in February 2025.
Pixabay/Public Domain
Quality of life improvements were notable, with significant gains in range of movement, stiffness, and pain reduction. Importantly, pimicotinib demonstrated a favorable safety profile: while all patients experienced some adverse events, only 4.8% were serious, and there were no signs of liver toxicity, a key differentiator from other therapies.
TGCT, a rare non-cancerous joint tumour, often recurs after surgery, making effective drug options crucial. Merck & Co., Inc. (NYSE:MRK), having secured global rights from Abbisko in March 2025, has filed for approval in China and plans an FDA submission by year-end. Full results will be presented at ASCO 2025 in Chicago.
While we acknowledge the potential of MRK to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRK and that has 100x upside potential, check out our report about this
READ NEXT: and
Disclosure: None.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hudbay Minerals (HBM) Climbs 15% on Stellar Earnings, $600-Million Investment From Mitsubishi
Hudbay Minerals (HBM) Climbs 15% on Stellar Earnings, $600-Million Investment From Mitsubishi

Yahoo

time9 minutes ago

  • Yahoo

Hudbay Minerals (HBM) Climbs 15% on Stellar Earnings, $600-Million Investment From Mitsubishi

We recently published . Hudbay Minerals Inc. (NYSE:HBM) is one of the best-performing stocks on Wednesday. Hudbay Minerals grew its share prices for a second day on Wednesday, up 15.03 percent to close at $11.33 apiece, following an impressive earnings performance and a $600-million investment from Mitsubishi Corp. In its updated report, Hudbay Minerals Inc. (NYSE:HBM) said it swung to a net income attributable to shareholders of $117.7 million from an attributable net loss of $16.5 million in the same period last year, driven by higher gross margins and strong cost control. Revenues increased by 26 percent to $536.4 million from $425.5 million year-on-year. 'With the strong performance in the first half of the year, we are reaffirming our full year consolidated production guidance and are favourably tracking well below our full year consolidated cost guidance for 2025,' said Hudbay Minerals Inc. (NYSE:HBM) President and CEO Peter Kukielski. For the full-year period, the company is targeting to produce between 117,000 and 149,000 tons of copper, as well as 247,500 to 308,000 ounces of gold. In other news, Hudbay Minerals Inc. (NYSE:HBM) was able to raise $600 million in fresh funds from Mitsubishi Corp. after the latter acquired a 30-percent stake in Copper World LLC. Under the agreement, Mitsubishi will pay an upfront cash of $420 million, with the balance to serve as a matching contribution within an 18-month period. While we acknowledge the potential of HBM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Chemours (CC) Soars 18% as Firm Expected to Benefit From AI, Chip Boom
Chemours (CC) Soars 18% as Firm Expected to Benefit From AI, Chip Boom

Yahoo

time9 minutes ago

  • Yahoo

Chemours (CC) Soars 18% as Firm Expected to Benefit From AI, Chip Boom

We recently published . The Chemours Company (NYSE:CC) is one of the best-performing stocks on Wednesday. Shares of The Chemours Company (NYSE:CC) soared by 17.95 percent on Wednesday to close at $14.65 apiece as investors cheered the successful qualification of its Opteon cooling liquid from Samsung Electronics, marking a significant milestone amid the growing demands from AI and semiconductor firms. In a statement, The Chemours Company (NYSE:CC) said its Opteon two-phase immersion cooling fluid received Samsung's qualification and compatibility with its 4th generation Solid State Drives (SSD), providing certainty to server manufacturers and increased adoption. 'Our innovative technology offers superior compatibility, enables higher IT loads, with fewer equipment failures, and dramatically less energy and water use—all of which translates to reduced costs for downstream users. We're eager to continue working with Samsung and the broader industry to bring this breakthrough technology to market,' said Denise Dignam, president and CEO of The Chemours Company (NYSE:CC). To ensure swift qualification, the firm partnered with Samsung, tank manufacturer Liquid Stack, and semiconductor firm PKI Corp. to conduct performance testing using a commercial-scale 48U immersion cooling tank. Samsung and PKI established a robust testing and qualification process to support current and future generation qualifications. The equipment met all compatibility targets, with no sign of degradation. While we acknowledge the potential of CC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Mars says M&M's, Starbursts without synthetic dyes coming in 2026
Mars says M&M's, Starbursts without synthetic dyes coming in 2026

The Hill

time10 minutes ago

  • The Hill

Mars says M&M's, Starbursts without synthetic dyes coming in 2026

Video above: FDA announces in April 2025 that it will phase out food dyes. (NEXSTAR) — While several other food companies had confirmed they would drop artificial food dyes in response to a mission set forth by Health and Human Services Secretary Robert F. Kennedy Jr. earlier this summer, Mars Wrigley was considered a holdout. That quietly changed late last month. In a late-July statement, which was first reported by Bloomberg on Thursday, Mars Wrigley North America announced it plans to release 'product options' made without artificial dyes in 2026. These options without synthetic dyes will be available only across four of its brands to start, according to the statement: M&M's, Skittles Original, Extra Gum Spearmint, and Starburst Original fruit chews. They'll be available to purchase online throughout the U.S. A spokesperson confirmed to Nexstar that the 'choice products' without artificial dyes will be additions to the current brands. They declined to say whether currently available products will be affected by the dye changes. AT&T reached a $177M settlement over data breaches: Will you get a payment? Mars did not immediately respond to Nexstar's request for additional information, like whether these options will replace others within each brand's portfolio, or if currently available products would be otherwise impacted. 'When we have identified fully effective, scalable solutions across the entire portfolio, we will share additional item commitments and timelines,' the company said in its statement. In April, Food and Drug Administration Commissioner Marty Makary said the agency would move to eliminate several synthetic dyes by the end of next year. That includes Green 3, Red 40, Yellow 5, Yellow 6, Blue 1, and Blue 2. Red 3 was set to be banned in food by 2027 because it caused cancer in laboratory rats; the FDA called for that deadline to move up. The FDA has been relying on companies voluntarily ditching the aforementioned dyes, but does plan to establish a standard and timeline for the food industry to switch to natural alternatives and revoke authorization for dyes not in production. Additionally, the FDA said it would authorize four new natural color additives. Several food manufacturers have already announced plans to ditch synthetic colors. That includes General Mills, Pepsico, ConAgra, Nestle, McCormick, Tyson Foods, Sam's Club, JM Smucker, Hershey, Kraft Heinz, and dozens of companies that make ice cream and frozen dairy desserts. Mars, however, was a holdout as of mid-July. The company now stands to be among the first to have products without artificial dyes available. Artificial dyes are used widely in U.S. foods. In Canada and in Europe — where synthetic colors are required to carry warning labels — manufacturers mostly use natural substitutes. Several states, including California and West Virginia, have passed laws restricting the use of artificial colors in foods. Health advocates have long called for the removal of artificial dyes from foods, citing mixed studies indicating they can cause neurobehavioral problems, including hyperactivity and attention issues, in some children. The FDA has maintained that the approved dyes are safe and that 'the totality of scientific evidence shows that most children have no adverse effects when consuming foods containing color additives.' The FDA currently allows 36 food color additives, including eight synthetic dyes. Removing dyes from the food supply will not address the chief health problems that plague Americans, said Susan Mayne, a Yale University chronic disease expert and former director of the FDA's food center. 'With every one of their announcements, they're focusing in on something that's not going to accomplish what they say it is,' Mayne said of Kennedy's initiatives. 'Most of these food dyes have been in our food supply for 100 years. … So why aren't they driving toward reductions in things that do drive chronic disease rates?'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store